Vanda Pharmaceuticals Inc.Vanda Pharmaceuticals Inc.Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc.

No trades
No trades

Fundamentals and stats

EPS and revenue snapshot

In the last quarter, the company reported −0.91 EUR per share, beating the −0.51 EUR estimate by −78.54%. Revenue for the same period reached ‪44.24 M‬ EUR, despite the estimate of ‪54.22 M‬ EUR. For the next quarter, analysts expect −0.59 EUR in earnings per share and ‪60.14 M‬ EUR in revenue.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise